Skip to main content
Medical information Clinical review pending

Infection Testing

Cryptococcus Antigen Rapid Test

Detects Cryptococcus antigens in blood or CSF, crucial for diagnosing fungal infections, especially cryptococcal meningitis in immunocompromised individuals.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Serum or Cerebrospinal Fluid (CSF). Confirm specific requirements with the laboratory before booking.
Results
Same-day reporting for samples submitted by 4 PM. Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Confirm with the laboratory before booking.
Test priceKSh 3,697

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Cryptococcus Antigen Rapid Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected cryptococcal meningitis
  • ✓Patients with HIV/AIDS presenting with neurological symptoms
  • ✓Immunocompromised individuals with fever or respiratory symptoms
  • ✓Monitoring response to cryptococcal treatment
  • ✓Diagnosis in patients with known exposure
02

In plain language

What this test helps you understand

Diagnosis of cryptococcal infections, particularly cryptococcal meningitis, especially in immunocompromised patients.
The Cryptococcus Antigen Rapid Test is a vital diagnostic tool used to detect the presence of Cryptococcus neoformans, a fungus that can lead to serious infections, particularly in individuals with weakened immune systems. This test is especially important for patients with HIV/AIDS, who are at higher risk of developing cryptococcal meningitis, a severe fungal infection affecting the brain.

This rapid test measures the levels of Cryptococcus antigens in the blood or cerebrospinal fluid (CSF). Identifying these antigens allows healthcare providers to diagnose infections early and start appropriate treatment, which is crucial for improving patient outcomes.

Individuals who should consider this test include those with compromised immune systems (like HIV/AIDS patients), people showing symptoms of meningitis (severe headache, fever, neck stiffness), and patients with a history of cryptococcal infections or exposure to environments where the fungus is common.

Benefits include quick results (same-day reporting for samples submitted by 4 PM), non-invasive sample collection (small serum or CSF sample), and guidance for treatment decisions.

Interpreting results should be done with a healthcare provider. A positive result suggests an active infection. A negative result doesn't completely rule out infection, especially in immunocompromised patients; further testing might be needed based on symptoms and risk factors.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Confirm with the laboratory before booking.
SampleSerum or Cerebrospinal Fluid (CSF). Confirm specific requirements with the laboratory before booking.
MethodologyLateral Flow Immunoassay (Rapid Test). Confirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
A negative result does not completely exclude cryptococcal infection, especially in immunocompromised individuals. Cross-reactivity with other fungal antigens may occur. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Cryptococcus is a type of fungus found in the environment, particularly in soil and bird droppings. It can cause serious infections, especially in people with weakened immune systems.
Individuals with compromised immune systems, such as those with advanced HIV/AIDS, organ transplant recipients, or those on immunosuppressive medications, are at the highest risk.
Symptoms can include severe headache, fever, stiff neck, confusion, sensitivity to light, nausea, and vomiting. Symptoms can develop gradually.
The test is performed on a sample of your blood (serum) or cerebrospinal fluid (CSF). A small amount of the sample is used in a rapid diagnostic test.
Results are typically available the same day if the sample is submitted to the laboratory by 4 PM. Confirm with the laboratory before booking.
A positive result indicates the presence of Cryptococcus antigens, suggesting an active infection. Your doctor will discuss the results and next steps with you.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp